# ExAblate Transcranial MRgFUS of the Subthalamic Nucleus for Treatment of Parkinson's Disease

> **NCT02246374** · NA · COMPLETED · sponsor: **InSightec** · enrollment: 7 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DEVICE:** ExAblate Transcranial System

## Key facts

- **NCT ID:** NCT02246374
- **Lead sponsor:** InSightec
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2021-05
- **Final completion:** 2021-05-18
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02246374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02246374, "ExAblate Transcranial MRgFUS of the Subthalamic Nucleus for Treatment of Parkinson's Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02246374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*